The global blood culture test market size is expected to reach USD 9.72 Billion in 2030 and register a revenue CAGR of 9.6% over the forecast period, according to latest report by Reports and Data. Increasing incidence of bloodstream infections, sepsis, and infectious diseases is expected to drive market revenue growth during the forecast period. Growing demand for blood culture tests in developing countries is also expected to boost revenue growth of the market.
Bloodstream Infections (BSIs) are infectious disorders caused by active bacterial or fungal germs in the bloodstream, which cause an inflammatory response shown by changes in clinical, laboratory, and hemodynamic parameters. Infections of the bloodstream are one of the major causes of deaths worldwide, and such illnesses extend time spent in hospitals, along with increasing the cost of treatment. Demand for advanced blood culture techniques that aid in early diagnosis of infections is expected to increase due increasing prevalence of BSIs, which in turn, is expected to boost revenue growth of the global blood culture test market during the forecast period.
However, increasing costs of automated equipment and lack of laboratory professionals are expected to hamper revenue growth of the market during the forecast period. Automated blood culture devices are expensive, as they have complex features and functions. For instance, automated equipment for Polymerase Chain Reaction (PCR) test costs between USD 15,000 and USD 20,000. Academic research laboratories usually cannot afford such high-priced systems due to financial constraints, and moreover, the overall cost of ownership of these instruments increases due to maintenance charges and a number of additional factors. This is a key barrier to the adoption of automated blood culture instruments, particularly among small-scale end users. There is increasing need for medical laboratory experts, but the number of new students graduating from clinical laboratory programs is dropping due to program closures. This is creating a major challenge in the growth of blood culture test market.
Top Companies Profiled in the Report Include:
Competitive landscape of the global blood culture test market is moderately consolidated with a few key players operating on global and regional levels. Key players are engaged in platform development and strategic alliances to expand their respective portfolios and gain robust footing in the global market. Major players in the market include Becton, Dickinson and Company, Thermo Fisher Scientific Corporation, Luminex Corporation, Danaher Corporation, Bruker Corporation, Ibis Biosciences, Inc., F. Hoffmann-La Roche AG, Meditech Technologies India Pvt. Ltd., Magnolia Medical Technologies, and Carl Zeiss AG.
Blood Culture Tests Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Major Highlights of the Blood Culture Tests Market Report:
- Conventional segment is expected to account for largest revenue share in the global blood culture test market over the forecast period, owing to rising use of convetional or traditional blood culture methods in independent clinical laboratories, hospitals, and pathology labs.
- Consumable segment is expected to register a steady revenue growth rate over the forecast period, due to increase in demand for blood culture media, assays, kits, and reagents.
- Molecular technology segment is expected to register a rapid revenue growth rate over the forecast period, due to increase in demand for improved equipment in hospitals and laboratories for infectious disease diagnostics.
- The blood culture test market in North America is expected to account for largest revenue share in the global market over the forecast period. Rising awareness about new diagnostic methods and presence of well-established healthcare facilities in the region are expected to drive North America market revenue growth.
- Companies profiled in the global market report include Becton, Dickinson and Company, Thermo Fisher Scientific Corporation, Luminex Corporation, Danaher Corporation, Bruker Corporation, Ibis Biosciences, Inc., Hoffmann-La Roche AG, Meditech Technologies India Pvt. Ltd., Magnolia Medical Technologies, and Carl Zeiss AG.
Additionally, the report consists a detailed analysis of the segmentation of the Blood Culture Tests Market based on product types and end-use/application offered in the Blood Culture Tests Market -
Method Outlook (Revenue, USD Billion; 2019-2030)
- Conventional/Manual Method
- Automated Method
Product Outlook (Revenue, USD Billion; 2019-2030)
- Instruments
- Automated Blood Culture System
- Supporting Laboratory Equipment
- Incubators
- Microscopes
- Colony Counters
- Gram Stainers
- Consumable
- Blood Culture Accessories
- Assay Kits and Reagents
- Blood Culture Media
- Aerobic Blood Culture Media
- Pediatric Aerobic Blood Culture Media
- Fungi/Yeast Blood Culture Media
- Software and Service
Application Outlook (Revenue, USD Billion; 2019-2030)
- Bacterial
- Fungal
- Micro-Bacterial
Technology Outlook (Revenue, USD Billion; 2019-2030)
- Culture Based Technology
- Molecular Technology
- Microarray
- Polymerase Chain Reaction (PCR)
- PNA-FISH
- Proteomic Technology
End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals and Diagnostic Centers
- Academic Research Laboratories
Key Regional Markets Studied in the Report:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Request for Customization this report - https://www.reportsanddata.com/request-customization-form/1461
